Anthropic IPO targets: Analysts see 15-50% upside before ANT debut
Independent analysts have set price targets for Anthropic's upcoming IPO ranging from $92 to $105 per share, well above the official $70-$78 range, ahead of the Class A shares debuting on Nasdaq Thursday under ticker ANT. Underwriting banks are in a research blackout and have not published targets. New Street Research leads with a $105 target and Buy rating, citing AI's rapid adoption in knowledge work, while Freedom Finance ($101.90) and KGI Securities ($100) also issued Buy or Outperform ratings. Morningstar set a $92 fair value, implying roughly 18-24% upside from the official range's midpoint, though it noted risks from compute spending and GAAP losses. The targets imply 15-50% upside depending on the final pricing, with reports suggesting Anthropic may price above $80. Under FINRA rules, underwriters like Goldman Sachs and Morgan Stanley cannot publish research for 10 days post-IPO, leaving independent estimates as the primary guidance for early trading.